BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 21575957)

  • 1. The interactions between doxorubicin and amphiphilic and acidic β-sheet peptides towards drug delivery hydrogels.
    Zarzhitsky S; Rapaport H
    J Colloid Interface Sci; 2011 Aug; 360(2):525-31. PubMed ID: 21575957
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Peptide-conjugated PAMAM for targeted doxorubicin delivery to transferrin receptor overexpressed tumors.
    Han L; Huang R; Liu S; Huang S; Jiang C
    Mol Pharm; 2010 Dec; 7(6):2156-65. PubMed ID: 20857964
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Controlling Doxorubicin Release from a Peptide Hydrogel through Fine-Tuning of Drug-Peptide Fiber Interactions.
    Elsawy MA; Wychowaniec JK; Castillo Díaz LA; Smith AM; Miller AF; Saiani A
    Biomacromolecules; 2022 Jun; 23(6):2624-2634. PubMed ID: 35543610
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Doxorubicin-polyphosphazene conjugate hydrogels for locally controlled delivery of cancer therapeutics.
    Chun C; Lee SM; Kim CW; Hong KY; Kim SY; Yang HK; Song SC
    Biomaterials; 2009 Sep; 30(27):4752-62. PubMed ID: 19520429
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Compressibility and elasticity of amphiphilic and acidic β-sheet peptides at the air-water interface.
    Vaiser V; Rapaport H
    J Phys Chem B; 2011 Jan; 115(1):50-6. PubMed ID: 21141953
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Coordinate bonding strategy for molecularly imprinted hydrogels: toward pH-responsive doxorubicin delivery.
    Zhang Q; Zhang L; Wang P; Du S
    J Pharm Sci; 2014 Feb; 103(2):643-51. PubMed ID: 24395706
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Self-assembled oligopeptide nanostructures for co-delivery of drug and gene with synergistic therapeutic effect.
    Wiradharma N; Tong YW; Yang YY
    Biomaterials; 2009 Jun; 30(17):3100-9. PubMed ID: 19342093
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Co-delivery of PDTC and doxorubicin by multifunctional micellar nanoparticles to achieve active targeted drug delivery and overcome multidrug resistance.
    Fan L; Li F; Zhang H; Wang Y; Cheng C; Li X; Gu CH; Yang Q; Wu H; Zhang S
    Biomaterials; 2010 Jul; 31(21):5634-42. PubMed ID: 20430433
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antitumor efficacy of doxorubicin-loaded laponite/alginate hybrid hydrogels.
    Gonçalves M; Figueira P; Maciel D; Rodrigues J; Shi X; Tomás H; Li Y
    Macromol Biosci; 2014 Jan; 14(1):110-20. PubMed ID: 23966317
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of pH and calcium ions on the stability of amphiphilic and anionic β-sheet peptide hydrogels.
    Zarzhitsky S; Edri H; Azoulay Z; Cohen I; Ventura Y; Gitelman A; Rapaport H
    Biopolymers; 2013 Nov; 100(6):760-72. PubMed ID: 23893547
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Self-assembled nucleo-tripeptide hydrogels provide local and sustained doxorubicin release.
    Baek K; Noblett AD; Ren P; Suggs LJ
    Biomater Sci; 2020 Jun; 8(11):3130-3137. PubMed ID: 32352097
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Doxorubicin-reinforced supramolecular hydrogels of RGD-derived peptide conjugates for pH-responsive drug delivery.
    Mei L; Xu K; Zhai Z; He S; Zhu T; Zhong W
    Org Biomol Chem; 2019 Apr; 17(15):3853-3860. PubMed ID: 30938396
    [TBL] [Abstract][Full Text] [Related]  

  • 13. pH triggered injectable amphiphilic hydrogel containing doxorubicin and paclitaxel.
    Zhao L; Zhu L; Liu F; Liu C; Shan-Dan ; Wang Q; Zhang C; Li J; Liu J; Qu X; Yang Z
    Int J Pharm; 2011 May; 410(1-2):83-91. PubMed ID: 21421032
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New insights into the mechanisms of the interactions between doxorubicin and the ion-exchange hydrogel DC Bead™ for use in transarterial chemoembolization (TACE).
    Biondi M; Fusco S; Lewis AL; Netti PA
    J Biomater Sci Polym Ed; 2012; 23(1-4):333-54. PubMed ID: 21255482
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tetrapeptide-based hydrogels: for encapsulation and slow release of an anticancer drug at physiological pH.
    Naskar J; Palui G; Banerjee A
    J Phys Chem B; 2009 Sep; 113(35):11787-92. PubMed ID: 19708711
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Complexation and release of doxorubicin from its complexes with pluronic P85-b-poly(acrylic acid) block copolymers.
    Tian Y; Bromberg L; Lin SN; Hatton TA; Tam KC
    J Control Release; 2007 Aug; 121(3):137-45. PubMed ID: 17630011
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Micellar nanocarriers assembled from doxorubicin-conjugated amphiphilic macromolecules (DOX-AM).
    del Rosario LS; Demirdirek B; Harmon A; Orban D; Uhrich KE
    Macromol Biosci; 2010 Apr; 10(4):415-23. PubMed ID: 20127669
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular design of peptide amphiphiles for controlled self-assembly and drug release.
    Liu Z; Tang X; Feng F; Xu J; Wu C; Dai G; Yue W; Zhong W; Xu K
    J Mater Chem B; 2021 Apr; 9(15):3326-3334. PubMed ID: 33881438
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug delivery with upconversion nanoparticles for multi-functional targeted cancer cell imaging and therapy.
    Wang C; Cheng L; Liu Z
    Biomaterials; 2011 Feb; 32(4):1110-20. PubMed ID: 20965564
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumoral acidic extracellular pH targeting of pH-responsive MPEG-poly(beta-amino ester) block copolymer micelles for cancer therapy.
    Ko J; Park K; Kim YS; Kim MS; Han JK; Kim K; Park RW; Kim IS; Song HK; Lee DS; Kwon IC
    J Control Release; 2007 Nov; 123(2):109-15. PubMed ID: 17894942
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.